{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:37:16Z","timestamp":1789749436522,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/00181"],"award-info":[{"award-number":["PI22\/00181"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RICORS2040 RD24\/0004\/0012"],"award-info":[{"award-number":["RICORS2040 RD24\/0004\/0012"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014181","name":"Extremadura Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014181","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejim.2025.106542","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:47:46Z","timestamp":1760060866000},"page":"106542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Endothelin-1 as dual marker for renal function decline and associated cardiovascular complications in patients with chronic kidney disease"],"prefix":"10.1016","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1648-0946","authenticated-orcid":false,"given":"Laura","family":"Gonz\u00e1lez-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2977-1357","authenticated-orcid":false,"given":"Manuel","family":"Mart\u00ed-Antonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Mota-Zamorano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8662-1435","authenticated-orcid":false,"given":"Celia","family":"Chicharro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3356-4040","authenticated-orcid":false,"given":"B\u00e1rbara","family":"Cancho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7993-7055","authenticated-orcid":false,"given":"Enrique","family":"Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3431-9469","authenticated-orcid":false,"given":"\u00c1lvaro","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9260-7672","authenticated-orcid":false,"given":"Zoraida","family":"Verde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Bandr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4984-6691","authenticated-orcid":false,"given":"Nicol\u00e1s R","family":"Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0524-9767","authenticated-orcid":false,"given":"Guillermo","family":"Gervasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2025.106542_bib0001","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2025.106542_bib0002","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/cvr\/cvad083","article-title":"Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association","volume":"119","author":"Zoccali","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ejim.2025.106542_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/biom14111393","article-title":"The dual burden: exploring cardiovascular complications in chronic kidney disease","volume":"14","author":"Caturano","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejim.2025.106542_bib0004","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41569-019-0176-3","article-title":"Endothelins in cardiovascular biology and therapeutics","volume":"16","author":"Dhaun","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ejim.2025.106542_bib0005","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40620-018-0514-2","article-title":"The association of endothelin-1 levels with renal survival in polycystic kidney disease patients","volume":"32","author":"Kocyigit","year":"2019","journal-title":"J Nephrol"},{"key":"10.1016\/j.ejim.2025.106542_bib0006","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41581-024-00908-z","article-title":"Endothelin receptor antagonists in chronic kidney disease","volume":"21","author":"Smeijer","year":"2025","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ejim.2025.106542_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/biology11050759","article-title":"Endothelin and the Cardiovascular system: the long journey and where we are going","volume":"11","author":"Haryono","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.ejim.2025.106542_bib0008","doi-asserted-by":"crossref","first-page":"eabf5074","DOI":"10.1126\/scitranslmed.abf5074","article-title":"Endothelin blockade prevents the long-term cardiovascular and renal sequelae of acute kidney injury in mice","volume":"14","author":"Czopek","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ejim.2025.106542_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13206056","article-title":"Endothelin inhibitors in chronic kidney disease: new treatment prospects","volume":"13","author":"Rakotoarison","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.ejim.2025.106542_bib0010","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.kint.2021.06.028","article-title":"Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: improving Global Outcomes (KDIGO) Consensus Conference","volume":"100","author":"Lameire","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2025.106542_bib0011","doi-asserted-by":"crossref","DOI":"10.3390\/life15040628","article-title":"Can Endothelin-1 help address the diagnostic and prognostic challenges in multimorbid acute heart failure patients?","volume":"15","author":"Dmour","year":"2025","journal-title":"Life"},{"key":"10.1016\/j.ejim.2025.106542_bib0012","first-page":"BC01","article-title":"Circulating Endothelin-1 as a diagnostic marker in patients with acute myocardial infarction: a cross-sectional study","volume":"19","author":"Rajendiran","year":"2025","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.ejim.2025.106542_bib0013","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41581-022-00616-6","article-title":"Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease","volume":"18","author":"Matsushita","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ejim.2025.106542_bib0014","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001624","article-title":"Plasma pro-endothelin-1 peptide concentrations rise in chronic kidney disease and following selective endothelin A receptor antagonism","volume":"4","author":"Dhaun","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejim.2025.106542_bib0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/0886022X.2018.1455586","article-title":"Predictive role of endothelin in left ventricular remodeling of chronic kidney disease","volume":"40","author":"Peng","year":"2018","journal-title":"Ren Fail"},{"key":"10.1016\/j.ejim.2025.106542_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910552","article-title":"The relationship between vascular biomarkers (Serum Endocan and Endothelin-1), NT-proBNP, and renal function in chronic kidney disease, IgA nephropathy: a cross-sectional study","volume":"25","author":"Sagi","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejim.2025.106542_bib0017","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/ckj\/sfs001","article-title":"Endothelin and the podocyte","volume":"5","author":"Barton","year":"2012","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ejim.2025.106542_bib0018","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1476-5381.2012.02070.x","article-title":"Endothelin-1 and the kidney\u2013beyond BP","volume":"167","author":"Dhaun","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ejim.2025.106542_bib0019","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.2337\/db15-1413","article-title":"Atrasentan reduces albuminuria by restoring the glomerular endothelial glycocalyx barrier in diabetic nephropathy","volume":"65","author":"Boels","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.ejim.2025.106542_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00060.2009","article-title":"Regulation of blood pressure and salt homeostasis by endothelin","volume":"91","author":"Kohan","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ejim.2025.106542_bib0021","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1161\/HYPERTENSIONAHA.123.21716","article-title":"Endothelin System in hypertension and chronic kidney disease","volume":"81","author":"Schiffrin","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.ejim.2025.106542_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2024.100833","article-title":"Sparsentan for focal segmental glomerulosclerosis in the DUET open-label extension: long-term efficacy and safety","volume":"6","author":"Campbell","year":"2024","journal-title":"Kidney Med"},{"key":"10.1016\/j.ejim.2025.106542_bib0023","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0140-6736(23)02302-4","article-title":"Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial","volume":"402","author":"Rovin","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2025.106542_bib0024","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa2308550","article-title":"Sparsentan versus Irbesartan in focal segmental glomerulosclerosis","volume":"389","author":"Rheault","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2025.106542_bib0025","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.ekir.2024.04.056","article-title":"Endothelial dysfunction biomarkers and CKD incidence in the REGARDS cohort","volume":"9","author":"Short","year":"2024","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ejim.2025.106542_bib0026","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/01.RES.69.1.209","article-title":"Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes","volume":"69","author":"Ito","year":"1991","journal-title":"Circ Res"},{"key":"10.1016\/j.ejim.2025.106542_bib0027","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1748-1716.1989.tb08772.x","article-title":"Characterization of the cardiovascular actions of endothelin in vivo: comparisons with neuropeptide Y and angiotensin II","volume":"137","author":"Pernow","year":"1989","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.ejim.2025.106542_bib0028","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4070\/kcj.2024.0354","article-title":"Prognostic value of plasma big endothelin-1 in patients hospitalized for heart failure","volume":"55","author":"Wang","year":"2025","journal-title":"Korean Circ J"},{"key":"10.1016\/j.ejim.2025.106542_bib0029","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-08181-1","article-title":"Serum big endothelin-1 is a significant biomarker of arterial stiffness in patients undergoing coronary artery bypass grafting","volume":"15","author":"Jhan","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejim.2025.106542_bib0030","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4093\/dmj.2023.0410","article-title":"Prognostic value of plasma Endothelin-1 in predicting worse outcomes in patients with prediabetes and Diabetes and stable coronary artery diseases","volume":"48","author":"Yang","year":"2024","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.ejim.2025.106542_bib0031","doi-asserted-by":"crossref","DOI":"10.1177\/11772719251318555","article-title":"Endothelin-1 as a candidate biomarker of systemic sclerosis: a GRADE-assessed systematic review and meta-analysis with meta-regression","volume":"20","author":"Mangoni","year":"2025","journal-title":"Biomark Insights"},{"key":"10.1016\/j.ejim.2025.106542_bib0032","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1161\/ATVBAHA.113.302028","article-title":"Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice","volume":"33","author":"Li","year":"2013","journal-title":"Arter Thromb Vasc Biol"},{"key":"10.1016\/j.ejim.2025.106542_bib0033","doi-asserted-by":"crossref","DOI":"10.36660\/abc.20240248i","article-title":"Serum nitric oxide, Endothelin-1 correlates post-procedural major adverse cardiovascular events among patients with acute STEMI","volume":"122","author":"Guo","year":"2025","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.ejim.2025.106542_bib0034","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1177\/1076029618764846","article-title":"The value of big endothelin-1 in the assessment of the severity of coronary artery calcification","volume":"24","author":"Wang","year":"2018","journal-title":"Clin Appl Thromb\/hemost: Off J Int Acad Clin Appl Thromb\/Hemost"},{"key":"10.1016\/j.ejim.2025.106542_bib0035","article-title":"C-Terminal-Pro-Endothelin-1 adds incremental prognostic value for risk stratification after ischemic stroke","volume":"11","author":"Westphal","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.ejim.2025.106542_bib0036","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1161\/CIRCULATIONAHA.111.063842","article-title":"Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease","volume":"125","author":"Sabatine","year":"2012","journal-title":"Circulation"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525004194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525004194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:21:10Z","timestamp":1781911270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620525004194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":36,"alternative-id":["S0953620525004194"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2025.106542","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endothelin-1 as dual marker for renal function decline and associated cardiovascular complications in patients with chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2025.106542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}],"article-number":"106542"}}